FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Glipizide Tablet, Extended Release
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Pfizer Inc. (New 03/17/2025)

Company Contact Information:
800-533-4535

Presentation	Posting Date	Related Information
Glucotrol XL, Tablet, Extended Release, 5 mg (NDC 0049-0174-02)	08/05/2024	Supply expected to exhaust mid September 2024; Discontinuation of the manufacture of the drug
Glucotrol XL, Tablet, Extended Release, 5 mg (NDC 0049-0174-03)	03/17/2025	Supply expected to exhaust early April 2025

Teva Pharmaceuticals USA, Inc. (New 02/06/2025)

Company Contact Information:
800-545-8800

Presentation	Posting Date	Related Information
Glipizide, Tablet, Extended Release, 5 mg (NDC 0591-0844-01)	02/06/2025	A business decision was made to discontinue manufacture of the drug.
Glipizide, Tablet, Extended Release, 5 mg (NDC 0591-0844-10)	02/06/2025	A business decision was made to discontinue manufacture of the drug.
Glipizide, Tablet, Extended Release, 10 mg (NDC 0591-0845-01)	02/06/2025	A business decision was made to discontinue manufacture of the drug.
Glipizide, Tablet, Extended Release, 10 mg (NDC 0591-0845-10)	02/06/2025	A business decision was made to discontinue manufacture of the drug.
Glipizide, Tablet, Extended Release, 2.5 mg (NDC 0591-0900-30)	02/06/2025	A business decision was made to discontinue manufacture of the drug.